Butylphthalide's Safety and Efficacy for Improving Neurological Function Prognosis in Patients With Cardiac Arrest (BNCA Trial)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.
Also called NCT06353334
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Tang Ziren
- Registry
-
NCT06353334
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06353334. Randomized; quadruple masking; primary purpose treatment. Start 2021-09-01 (actual); primary completion 2026-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Butylphthalide's Safety and Efficacy for Improving Neurological Function Prognosis in Patients With Cardiac Arrest (BNCA Trial)
- Condition
- Butylphthalide
- Condition
- Cardiac Arrest
- Condition
- Neuroprotective Drugs
- Intervention (Drug)
- Butylphthalide and Sodium Chloride Injection
- Intervention (Drug)
- Saline Solution
- Lead sponsor
- Tang Ziren
Record details
- Record id
cardio:ct-nct06353334- Content hash
69b3e0f84f26ebb018a5cf681f6cb7646775df16849c2c33c81d7f3f42f32bdb